CTOR vs K · $105.2M cap vs P/E 23, $29.03B cap
Citius Oncology, Inc. (CTOR) versus Kellanova (K) — a side-by-side from cached financials, not a winner call.
Citius Oncology, Inc. (CTOR) is a drug manufacturers - specialty & generic company listed on US.
Kellanova (K) is a packaged foods company listed on US.
CTOR does not have a complete income-statement cache yet.
K does not have a complete income-statement cache yet.
CTOR currently screens at market cap $105.2M. K currently screens at market cap $29.03B and trailing P/E 22.8.
Not investment advice. Open the CTOR and K stock pages for the full models.
Not investment advice.